Priority Review Granted by FDA to Olaparib in Castration-Resistant Prostate Cancer
Treatment Trends in Prostate Cancer at MD Anderson Versus Nationwide
At-Home Urine Collection as a Diagnostic Tool for Prostate Cancer
MRI-Guided Ultrasound Technique for Localized Prostate Cancer
Early-Phase Study of Antibody-Drug Conjugate in Castration-Resistant Prostate Cancer
Can Statins Lower the Risk of Aggressive Prostate Cancer?
Novel Biomarker for Early Prostate Cancer Under Study
Prospective Implications of BRCA Mutations in Prostate Cancer
Beyond the Guidelines: Investigator Perspectives on Current Clinical Issues and Ongoing Research in the Systemic Treatment of Prostate Cancer
Cases From the Community: Clinical Investigators Provide Their Perspectives on the Use of Immune Checkpoint Inhibitors in the Management of Actual Patients With Genitourinary Cancers
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care – Prostate Cancer
Current Approaches to the Treatment of Metastatic Castration-Resistant Prostate Cancer
Huntsman Cancer Institute
Siteman Cancer Center
Yale Cancer Center
Moffitt Cancer Center
Enzalutamide
Apalutamide
Us TOO International Prostate Cancer Education and Support Network
CancerCare
Prostate Conditions Education Council (PCEC)
National Alliance of State Prostate Cancer Coalitions (NASPCC)
